# Bioequivalence Study Of Glucotrol XL 2.5 Mg Tablets

> **NCT00550329** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 32 (—)

## Conditions studied

- Diabetes Mellitus, Non-Insulin-Dependent
- Hyperglycemia

## Interventions

- **DRUG:** Glipizide GITS

## Key facts

- **NCT ID:** NCT00550329
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** —
- **Final completion:** 2007-11
- **Target enrollment:** 32 (—)
- **Last updated:** 2008-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00550329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00550329, "Bioequivalence Study Of Glucotrol XL 2.5 Mg Tablets". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00550329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*